These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 8055787

  • 21. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.
    Jenkins PJ, Emery M, Howling SJ, Evanson J, Besser GM, Monson JP.
    Horm Res; 2004; 62(5):227-32. PubMed ID: 15477693
    [Abstract] [Full Text] [Related]

  • 22. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.
    Moses AC, Molitch ME, Sawin CT, Jackson IM, Biller BJ, Furlanetto R, Reichlin S.
    J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607
    [Abstract] [Full Text] [Related]

  • 23. [Effectiveness of using Parlodel in acromegaly].
    Vasiukova EA, Pisarskaia IV, Zefirova GS, Ibragimova GV.
    Klin Med (Mosk); 1979 Aug; 57(8):22-4. PubMed ID: 502407
    [No Abstract] [Full Text] [Related]

  • 24. The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
    Karavitaki N, Botusan I, Radian S, Coculescu M, Turner HE, Wass JA.
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):282-8. PubMed ID: 15730408
    [Abstract] [Full Text] [Related]

  • 25. [Long acting sandostatine (sandostatine LAR) in the treatment of acromegaly].
    Priou A, Levesque G, Simonetta C, Lancranjan I, Roger P, Jaquet P.
    Ann Endocrinol (Paris); 1995 Mar; 56(3):213-8. PubMed ID: 7677407
    [Abstract] [Full Text] [Related]

  • 26. Long-term bromocriptine treatment and somatostatin in acromegaly.
    Gáspár L, László FA.
    Endokrinologie; 1980 Oct; 76(2):152-62. PubMed ID: 6108852
    [Abstract] [Full Text] [Related]

  • 27. [Long-term treatment of acromegaly with bromocriptine (Parlodel R)].
    Dolecek R, Závada M.
    Vnitr Lek; 1977 Sep; 23(10):994-1001. PubMed ID: 411250
    [No Abstract] [Full Text] [Related]

  • 28. [Effect of acute parlodel load on the prolactin and STH content in patients with various neuroendocrine diseases].
    Mel'nichenko GA, Bol'shakova TD, Gitel' EP, Langner TK, Barkova MV.
    Probl Endokrinol (Mosk); 1983 Sep; 29(1):19-23. PubMed ID: 6682222
    [Abstract] [Full Text] [Related]

  • 29. Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly.
    Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F.
    Growth Horm IGF Res; 2005 Jun; 15(3):200-6. PubMed ID: 15935982
    [Abstract] [Full Text] [Related]

  • 30. Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years.
    Besser GM, Wass JA.
    Med J Aust; 1978 Nov 04; 2(3 Suppl):31-3. PubMed ID: 745579
    [Abstract] [Full Text] [Related]

  • 31. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG, Cozzi R, Dallabonzana D, Oppizzi G, Verde G, Petroncini M, Liuzzi A, del Pozo E.
    J Clin Endocrinol Metab; 1987 Mar 04; 64(3):447-53. PubMed ID: 2880861
    [Abstract] [Full Text] [Related]

  • 32. [Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
    Molitvoslovova NN.
    Sov Med; 1984 Mar 04; (1):24-9. PubMed ID: 6701649
    [No Abstract] [Full Text] [Related]

  • 33. [Effect of bromocriptin (Parlodel) in acromegaly. Successful pregnancy during treatment].
    Espersen T, Ingerslev J, Ditzel J.
    Ugeskr Laeger; 1978 Sep 04; 140(36):2177-9. PubMed ID: 684946
    [No Abstract] [Full Text] [Related]

  • 34. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
    Lamberts SW, Zweens M, Verschoor L, del Pozo E.
    J Clin Endocrinol Metab; 1986 Jul 04; 63(1):16-9. PubMed ID: 2872225
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
    Barkan AL, Kelch RP, Hopwood NJ, Beitins IZ.
    J Clin Endocrinol Metab; 1988 Jan 04; 66(1):16-23. PubMed ID: 2891720
    [Abstract] [Full Text] [Related]

  • 39. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
    Chiba T, Chihara K, Minamitani N, Goto B, Kadowaki S, Taminato T, Matsukura S, Fujita T.
    Horm Metab Res; 1982 Feb 04; 14(2):57-61. PubMed ID: 7040191
    [Abstract] [Full Text] [Related]

  • 40. A comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly.
    Fløgstad AK, Halse J, Grass P, Abisch E, Djøseland O, Kutz K, Bodd E, Jervell J.
    J Clin Endocrinol Metab; 1994 Aug 04; 79(2):461-5. PubMed ID: 8045964
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.